VGNX -- Variagenics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VGNX -- Variagenics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (205)	11/1/2002 6:17:01 PM
From: scaram(o)uche	Read Replies (1) of 269

IDENTIFICATION OF GENETIC COMPONENTS OF DRUG RESPONSE Patent Number: Publication date: 2002-10-16 Inventor(s): STANTON VINCENT P JR (US) Applicant(s): VARIAGENICS INC (US); STANTON VINCENT P JR (US) Requested Patent: EP1248832 Application Number: EP20010903248 20010122 Priority Number(s): WO2001US02223 20010122; US20000177522P 20000121 (no link up yet to application, therefore no abstract yet available)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next